Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
The Barre-Montpelier Times Argus
14d

CASI Pharmaceuticals Announces Approval of Clinical Trial Application by China NMPA for Phase 1 / 2 Study of CID-103 for Renal Allograft Antibody-Mediated Reje…

CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody; binds to unique CD38 epitopeAMR is a leading cause of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Democrats, WH reach deal
On ICE operations in MN
Richardson charged
Exits A24 film 'Deep Cuts'
Sentenced to 20 years
Waymo vehicle hits child
Veteran publicist dies
Dunn announces retirement
DOJ files federal charges
Eagles hire Sean Mannion
Enters CA governor's race
US life expectancy report
Shooting in Canada
Man tried to free Mangione
Chiles granted appeal
Launches MN governor bid
To announce Fed chief nominee
ICE ends Maine surge
US trade deficit widens
Allen undergoes surgery
ISR returns Palestinian bodies
Sues IRS, Treasury
US cricket star suspended
Shortens Clash schedule
Join National Film Registry
Brendan Banfield testifies
To invest in OpenAI?
  • Privacy
  • Terms